RAC Regulatory Strategic Planning 4

Question 1

Under 21 CFR Part 312, a Type B meeting with FDA is most commonly used to discuss:

Accepted Answer

End-of-Phase 2 issues and pre-NDA/BLA discussions

Answer

Type B meetings include End-of-Phase 1, End-of-Phase 2, pre-NDA/BLA, and pre-BLA meetings — they are milestone meetings that occur at defined stages of drug development.

Question 2

In a global regulatory strategy, which factor most significantly influences the sequence of country submissions?

Accepted Answer

Commercial opportunity, unmet medical need, and regulatory complexity in each market

Answer

Submission sequence is strategically determined by factors including market potential, patient access urgency, regulatory precedent-setting value, and agency workload.

Question 3

Which of the following best describes 'regulatory risk' in the context of a product development strategy?

Accepted Answer

The likelihood and impact of events that could delay or prevent regulatory approval

Answer

Regulatory risk encompasses the probability and potential impact of events—such as insufficient clinical data, manufacturing issues, or label disputes—that could jeopardize or delay approval.

Question 4

A company's product has received a Complete Response Letter (CRL) from FDA. The strategic next step should be:

Accepted Answer

Carefully analyze the deficiencies cited and request a Type A meeting to discuss the path forward

Answer

After a CRL, analyzing the specific deficiencies and meeting with FDA (Type A meeting) to clarify the agency's concerns is the standard strategic response.

Question 5

The FDA's 'Accelerated Approval' pathway allows approval based on:

Accepted Answer

A surrogate or intermediate clinical endpoint reasonably likely to predict clinical benefit

Answer

Accelerated Approval allows use of surrogate or intermediate clinical endpoints reasonably likely to predict clinical benefit, with post-approval confirmatory trials required.

(RAC) Regulatory Affairs Certification Practice Test

(RAC) Regulatory Affairs Certification Practice Test

RAC Regulatory Strategic Planning 4